Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

597 ARTÍCULOS , VIENDO DEL 91 AL 105

Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients

Lima-Silva TB, Bahia VS, Cecchini MA, Cassimiro L, Guimarães HC, Gambogi LB, Caramelli P, Balthazar M, Damasceno B, Brucki SMD, de Souza LC, Nitrini R, Mioshi E, Yassuda MS.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):220-225. doi: 10.1097/WAD.0000000000000246.

Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care

Möhler R, Renom A, Renom H, Meyer G.

Cochrane Database Syst Rev. 2018 Feb 13;2(2):CD009812. doi: 10.1002/14651858.CD009812.pub2.

Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group

Taragano FE, Allegri RF, Heisecke SL, Martelli MI, Feldman ML, Sánchez V, García VA, Tufro G, Castro DM, Leguizamón PP, Guelar V, Ruotolo E, Zegarra C, Dillon C.

J Alzheimers Dis. 2018;62(1):227-238. doi: 10.3233/JAD-170632.

Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases

Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Aarsland D, Orzi F, Buttinelli C, Giubilei F, Onofrj M, Stocchi F, Vacca L, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Garn H, Fraioli L, Pievani M, Frisoni GB, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Başar E, Yener G, Emek-Savaş DD, Triggiani AI, Franciotti R, Taylor JP, De Pandis MF, Bonanni L.

J Alzheimers Dis. 2018;62(1):247-268. doi: 10.3233/JAD-170703.

Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers

Lang B, Kindy MS, Kozel FA, Schultz SK, Taheri S.

J Alzheimers Dis. 2018;62(1):39-60. doi: 10.3233/JAD-170733.

Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI

Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

J Alzheimers Dis. 2018;62(1):399-408. doi: 10.3233/JAD-170833.

Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias

Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, Etcharry-Bouyx F, Moreaud O, Pasquier F, Couratier P, Bennys K, Vercelletto M, Martinaud O, Laurent B, Pariente J, Puel M, Epelbaum S, Belliard S, Kaaouana T, Fillon L, Chupin M, Dubois B, Teichmann M; PHRC “CAPP” Study Group.

Neurology. 2018 Mar 20;90(12):e1057-e1065. doi: 10.1212/WNL.0000000000005165. Epub 2018 Feb 14.

Special Issue on mild behavioral impairment and non-cognitive prodromes to dementia

Mortby ME, Lyketsos CG, Geda YE, Ismail Z.

Int Psychogeriatr. 2018 Feb;30(2):167-169. doi: 10.1017/S1041610218000108.

Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Tréluyer JM, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert PH, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group.

Alzheimers Dement. 2018 Jul;14(7):858-868. doi: 10.1016/j.jalz.2018.01.004. Epub 2018 Feb 17.

Type 2 Diabetes Mellitus and Alzheimer's Disease: Overlapping Biologic Mechanisms and Environmental Risk Factors

Paul KC, Jerrett M, Ritz B.

Curr Environ Health Rep. 2018 Mar;5(1):44-58. doi: 10.1007/s40572-018-0176-1.

VaD - An Integrated Framework for Cognitive Rehabilitation

Balea M, Muresanu D, Alvarez A, Homberg V, Bajenaru O, Guekht A, Heiss WD, Popa L, Vester J, Muresanu I, Birle C, Slavoaca D.

CNS Neurol Disord Drug Targets. 2018 Apr 26;17(1):22-33. doi: 10.2174/1871527317666180219164545.

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting

Seitz DP, Chan CC, Newton HT, Gill SS, Herrmann N, Smailagic N, Nikolaou V, Fage BA.

Cochrane Database Syst Rev. 2018 Feb 22;2(2):CD011415. doi: 10.1002/14651858.CD011415.pub2.

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2018 Feb 23;18(1):57. doi: 10.1186/s12877-018-0748-9.

Dementia prevalence in a population at high vascular risk: the Trinidad national survey of ageing and cognition

Davis G, Baboolal N, Mc Rae A, Stewart R.

BMJ Open. 2018 Feb 22;8(2):e018288. doi: 10.1136/bmjopen-2017-018288.

Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition

Cohen AD, McDade E, Christian B, Price J, Mathis C, Klunk W, Handen BL.

Alzheimers Dement. 2018 Jun;14(6):743-750. doi: 10.1016/j.jalz.2018.01.002. Epub 2018 Mar 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias